ORAL IRON CHELATION WITH DEFERIPRONE
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 44 (1) , 235-247
- https://doi.org/10.1016/s0031-3955(05)70471-5
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Prevention of Anthracycline Cardiotoxicity by Iron ChelationActa Haematologica, 1996
- Clinical Studies of Iron Chelators in MalariaActa Haematologica, 1996
- Role of Deferoxamine in Tumor TherapyActa Haematologica, 1996
- Cardioprotective Effect of DesferrioxamineActa Haematologica, 1996
- XVI World Congress of Anatomic and Clinical PathologyThe American Journal of Surgical Pathology, 1991
- L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia majorBritish Journal of Haematology, 1990
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Treatment of acute iron ingestion with deferoxamine in 20 childrenThe Journal of Pediatrics, 1966
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964